Biotechnology company Moderna (NASDAQ:MRNA) announced better-than-expected revenue in Q2 CY2025, but sales fell by 41.1% year ...

Pulling the Pfizer EUA would remove the only COVID-19 vaccine approved for all children from the US market. The Moderna ...

Palivizumab was the only approved therapy to prevent severe RSV disease in infants and young children until the approval of nirsevimab in 2023.

Central Texas doctor's offices and care centers have noticed the annual summer COVID-19 spike in cases has been happening in ...

Central Texas doctor's offices and care centers have noticed the annual summer COVID-19 spike in cases has been happening in the past few weeks. It could be happening with new variants making their ...